Are polymorphisms in the ACE gene a potent genetic risk factor for restenosis?
Open Access
- 1 August 1994
- Vol. 72 (2) , 101
- https://doi.org/10.1136/hrt.72.2.101
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A potent genetic risk factor for restenosisNature Genetics, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.Circulation, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990